Public Policy

Future Trends in Behavioral Health Investment and Payer Dynamics
Public Policy Future Trends in Behavioral Health Investment and Payer Dynamics

While federal oversight has created short-term volatility, it is expected to improve long-term industry health by mitigating fraudulent activity. The behavioral health sector is currently navigating a period of profound transformation, shifting from a phase of rapid, generalized expansion to one

Legal Battle Over Mifepristone Challenges National Abortion Access
Public Policy Legal Battle Over Mifepristone Challenges National Abortion Access

Faisal Zain stands at the intersection of medical clinical excellence and regulatory strategy, bringing a wealth of experience in the manufacturing of the very diagnostic and treatment tools that define modern healthcare. As an expert in medical technology, Zain has witnessed the evolution of

St. Paul Clinic Closures Signal a Crisis in Safety-Net Care
Public Policy St. Paul Clinic Closures Signal a Crisis in Safety-Net Care

The recent shuttering of essential medical facilities in the heart of St. Paul represents more than just a localized logistical adjustment; it marks a dangerous pivot point for the city’s most marginalized residents who rely on community care for survival. As the healthcare landscape shifts toward c

Will S. 3097 Finally Close Digital Health Privacy Gaps?
Public Policy Will S. 3097 Finally Close Digital Health Privacy Gaps?

Every time an individual logs a heartbeat on a smartwatch or tracks a sleep cycle through a mobile application, they generate a trail of intimate biological data that remains largely outside the protective umbrella of federal privacy laws. The current digital health landscape is defined by this

FTC Sues Hims & Hers Over Data Privacy and Deceptive Billing
Public Policy FTC Sues Hims & Hers Over Data Privacy and Deceptive Billing

The FTC's litigation underscores a growing tension between aggressive digital marketing strategies and the traditional standards of patient-doctor confidentiality. As the telehealth sector has expanded rapidly, consumers have increasingly turned to digital platforms for discreet medical care,

Can China Balance Speed and Safety in Clinical Trials?
Public Policy Can China Balance Speed and Safety in Clinical Trials?

A man in his 50s participating in an in vivo CAR-T cell therapy trial died after treatment, yet the public remained unaware of the incident for an extended period. This tragic outcome, occurring within a landscape of hyper-accelerated medical innovation, highlights the growing tension between rapid

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later